Investors

By Laura Lovett 03:28 pm September 18, 2020
When Colette Courtion, founder and CEO of Joylux, which makes health tech products aimed at curbing vaginal atrophy, began to advertise, she quickly started getting ad rejections from social media giants. Her product, which was developed to help women with incontinence, vaginal dryness and other conditions related to aging and giving birth, is an intervaginal tool that bears resemblance to a...
By Dave Muoio 03:35 pm September 17, 2020
The increased adoption of virtual care technologies during the COVID-19 public health emergency is fairly well documented by this point, but a widespread embrace of health technologies is providing a similar upswell on individual niches within the digital health landscape. One such group of beneficiaries are the companies working to develop, validate and distribute digital therapeutics. Speaking...
By Dave Muoio 03:35 pm September 16, 2020
Israeli "digital X-ray" company Nanox is fielding increased scrutiny and a sizable hit to its share prices following the publication of a scathing report and commentary that referred to the company as "Theranos 2.0." The criticism was posted yesterday by activist short seller Andrew Left's Citron Research, an online stock analysis and commentary blog that has focused on identifying overpriced or...
By Laura Lovett 02:29 pm September 15, 2020
London-based virtual care provider Medefer landed £10M ($12.8M) in a funding round led by Nickleby Capital.  WHAT IT DOES Medefer is split into three services: a healthcare provider, virtual outpatient pathway and a tech platform for doctors to conduct virtual visits. Currently the platform can deliver healthcare within the UK's NHS system.  The platform allows patients to see a Medefer GP or a...
By Dave Muoio 11:48 am September 15, 2020
Medigate, a startup focused on cybersecurity for medical devices and other connected health products, has announced $30 million in Series B funding, bringing the company's lifetime raise to $50 million. Partech led the round, which also saw participation from Maor Investments and prior backers YL Ventures, U.S. Venture Partners and Blumberg Capital. WHAT IT DOES Medigate's platform secures ...
By Dave Muoio 11:37 am September 14, 2020
Major telehealth vendor MDLive announced this morning a new $50 million crossover equity investment from Sixth Street Growth. The company said that it has also obtained $25 million in debt financing from other unnamed investors. WHAT IT DOES MDLive provides a telehealth platform staffed by a network of certified clinicians capable of delivering virtual urgent care, dermatology, therapy and...
By Dave Muoio 04:53 pm September 11, 2020
International pharma Boehringer Ingelheim and prescription digital therapeutics company Click Therapeutics have inked a $500 million-plus deal to jointly develop and commercialize a digital treatment for patients with schizophrenia. The treatment, referred to as CT-155, will be a mobile app built on Click's proprietary tech platform, the companies said. Employing cognitive and neurobehavioral...
By MobiHealthNews 02:41 pm September 11, 2020
AmWell and GoodRx seem to be ushering in a second wave of digital health IPOs. Why is this happening now? And who's next? With Healthbox President and HIMSS EVP Neil Patel as their guest, the MobiHealth team (host Jonah Comstock, Managing Editor Laura Lovett and Associate Editor Mallory Hackett) dive into these questions and more. Plus, in the second half of the show, they discuss Amazon Halo,...
By Dr. Liz Kwo 12:00 pm September 11, 2020
About the author: Dr. Liz Kwo is currently the staff VP of clinical data analytics at Anthem, and previously cofounded and served as CEO of telemedicine second opinion company InfiniteMD. She received an MD from Harvard Medical, an MBA from Harvard Business School and an MPH from the Harvard T.H. Chan School of Public Health. COVID-19 has reshaped the way humans interact with technology in...
By Dave Muoio 02:14 pm September 10, 2020
Artificial intelligence drug discovery company Recursion Pharmaceuticals has announced an oversubscribed Series D funding round totaling $239 million. Headlining the raise is a strategic partnership with Bayer, which came with a $50 million investment from the Leaps by Bayer. Casdin Capital, Catalio Capital Management, Laurion Capital Management, Samsara BioCapital and all of the major...